Objective To investigate whether gray matter pathology above the level of injury, alongside white matter changes, also contributes to sensorimotor impairments after spinal cord injury.
Spinal cord injury (SCI) usually leads to sensorimotor dysfunction resulting from damage at the level of injury. However, a complex cascade of secondary neurodegenerative processes occur across the spinal cord and brain. 1 In chronic SCI, cervical cord atrophy of up to 30% has been reported above the level of injury; its magnitude relates to the degree of clinical impairment. 2 Recent improvements in diffusionweighted imaging and anatomic sequences with higher inplane resolution, 3 combined with advanced postprocessing techniques, 4, 5 now allow the assessment of gray and white matter changes in the cervical spinal cord occurring after SCI.
Although white matter pathology within the spinal cord contributes to sensorimotor impairments, the functional effects of gray matter pathology above the level of injury are uncertain. Improved understanding of tissue-specific cord pathology may allow more efficient targeting and monitoring of neuroregenerative and neuroprotective agents. This study therefore addresses to what extent cord atrophy above the level of injury is driven by pathophysiologic processes occurring in gray and white matter, whether lesion severity is associated with the magnitude of neurodegeneration above the level of injury, and whether the tissue-specific neurodegeneration is associated with neurophysiologic and clinical outcome.
Using structural and diffusion MRI data, we assessed tissuespecific cord pathology above the level of injury in patients with chronic SCI compared to healthy controls. These measures included the assessment of dorsal horn area (DHA) and ventral horn area (VHA), 6 diffusivity changes within the major spinal pathways, and associations between lesion severity, 7 tissuespecific pathology, and neurophysiologic changes.
Methods
Standard protocol approvals, registrations, and patient consents Our study protocol was designed in accordance with the Declaration of Helsinki and was approved by the local ethics committee of Zurich (KEK-ZH-Nr. 2012-0343, PB_2016-00623). All participants gave their written informed consent before participation.
Participants
We recruited 17 patients with SCI (mean age 48.7 ± 14.1 years, 3 female patients) between November 2014 and May 2016 who were preciously admitted to the University Hospital Balgrist (Zurich, Switzerland). Twenty-one healthy controls (mean age 41.7 ± 11.3 years, 7 female controls) from the local neighborhood served as a control dataset that was acquired and used in a previous study. 8 Inclusion criteria for patients with SCI were traumatic cervical SCI, no other neurologic or mental disorders affecting clinical outcome, age between 18 and 70 years, MRI compatible, and no pregnancy.
Clinical assessments
All patients were examined with comprehensive clinical protocols to assess neurologic and functional impairment. These included the International Standards for Neurological Classification of Spinal Cord Injury protocol for motor, light-touch, and pinprick score and completeness of injury 9 ; the Spinal Cord Independence Measure (SCIM) to measure daily life independence 10 ; the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) for assessing upper limb function 11 ; and the Walking Index for Spinal Cord Injury (WISCI). 12 All patients completed the full protocol, except GRASSP score was not available for 1 patient.
Neurophysiologic assessments
Contact heat evoked potentials (CHEPs) and somatosensory evoked potentials (SSEPs) were acquired bilaterally in patients at the dermatomes C4, C6, and C8 to measure the integrity of the spinothalamic tract (i.e., CHEPs) and the dorsal column (i.e., SSEPs). For the acquisition of CHEPs 13 and SSEPs, 14 the same protocols were applied as previously described.
Contact heat evoked potentials
A contact heat stimulator (PATHWAY Pain & Sensory Evaluation System, Medoc, Ramat Yishay, Israel) was used to deliver contact heat stimuli from a baseline temperature of 35°C to a peak temperature of 52°C with a heating rate of 70°C/s and a cooling rate of 40°C/s. For each dermatome, we first assessed heat perception and pain thresholds within 2 consecutive trials. For the CHEPs recording, scalp recording sites were prepared with Nuprep (D.O. Weaver & Co, Aurora, CO) and alcohol. Three 9-mm Ag/AgCl surface disk electrodes were positioned according to the international 10-20 system with the active electrode at the Cz position and referenced to linked earlobes (A1-A2); Glossary AD = axonal diffusivity; CHEP = contact heat evoked potential; CI = confidence interval; DCA = dorsal column area; DHA = dorsal horn area; DTI = diffusion tensor imaging; FA = fractional anisotropy; FOV = field of view; GMA = gray matter area; GRASSP = Graded Redefined Assessment of Strength, Sensibility and Prehension; MD = mean diffusivity; RD = radial diffusivity; SCA = spinal cord area; SCI = spinal cord injury; SCIM = Spinal Cord Independence Measure; SSEP = somatosensory evoked potential; VHA = ventral horn area; WISCI = Walking Index for Spinal Cord Injury; WMA = white matter area.
impedances were kept <5 kΩ. Ten to 15 contact heat stimuli were applied (interstimulus interval 8-12 seconds). Two seconds after each stimulus, an audio cue appeared, and patients rated their perceived intensity according to a numeric rating scale. All signals were sampled from 100 milliseconds before the trigger to 1,500 milliseconds after the trigger at a sampling rate of 2,000 Hz with a preamplifier (20,000× bandpass filter = 0.25-300 Hz; ALEA Solutions, Switzerland). Data were recorded in a LabView-based program (V1.43 CHEP; ALEA Solutions, Zurich, Switzerland) with a 100-millisecond period before the trigger and 1-second posttrigger period. Raw data were bandpass filtered from 0.5 to 30 Hz.
Somatosensory evoked potentials
For dermatomal SSEPs, Key Point (Medtronic, Mississauga, ON, Canada) was used to record and deliver electric stimulation of 3 Hz. Stimuli were elicited by single 0.2-millisecond, repetitive, square-wave electric stimulation. We first assessed electric perception and pain thresholds for each dermatome (not exceeding 40 mA) within 2 consecutive trials. For the recording of SSEPs, surface gel electrodes (10 mm) were used on each dermatome after the skin was prepared with Nuprep (D.O. Weaver & Co) and alcohol. Disposable needle electrodes (Spes Medica, Srl, Genova, Italy) were positioned according to the international 10-20 system with the active electrode positioned at the contralateral side for the stimulated dermatome (C3-4) referenced to Fz; impedances were kept <5 kΩ. The stimulation intensity was individually set as 3-fold electric perception threshold. Averages of 2 traces of 300 cortical responses were obtained for each dermatome. Raw data were bandpass filtered from 2 to 2,000 Hz.
Neurophysiologic classification
We determined amplitudes and latencies of each dermatome for each patient after averaging all single-trial waveforms for CHEPs (i.e., N2P2, N2, P2) and SSEPs (i.e., N1P1, N1, P1).
Furthermore, CHEPs and SSEPs were classified as normal (onset latency ≤2 SDs from control dermatome recording), pathologic (onset latency >2 SDs from control dermatome recording), or absent (not recordable).
14 The CHEPs protocol was acquired fully in 14 patients and partially in 1 patient. For SSEPs, 12 patients received the full protocol and 2 patients participated in part of the protocol.
Image acquisition
All imaging was performed on a clinical 3T Skyra Fit scanner (Siemens Healthcare, Erlangen, Germany) equipped with a 16-channel radiofrequency receive-only head and neck coil and a radiofrequency body transmit coil. A stiff neck (Laerdal Medicals, Stavanger, Norway) was used in all participants to minimize motion artifacts. As a result of motion artifacts, 1 patient was excluded from macrostructural analysis, and 3 patients had to be excluded from microstructural analysis.
At the lesion epicenter, a sagittal T1-weighted (repetition time 600 milliseconds, echo time 9.9 milliseconds, flip angle 150°, in-plane resolution 0.57 × 0.57 mm, slice thickness 3.3 mm), a sagittal T2-weighted (repetition time 3,500 milliseconds, echo time 84 milliseconds, flip angle 160°, in-plane resolution 0.34 × 0.34 mm, slice thickness 2.75 mm), and an axial T2-weighted image (repetition time 5,510 milliseconds, echo time 93 milliseconds, flip angle 150°, in-plane resolution 0.5 × 0.5 mm, slice thickness 3.6 mm) were acquired to assess the lesion size.
At the cervical cord above the level of injury (centered at C2-3), 5 volumes were acquired with a T2*-weighted 3-dimensional multiecho gradient recall echo sequence (multiple echo data image combination At the identical level, a high-resolution diffusion tensor imaging (DTI) dataset was acquired with a cardiac-gated reduced-FOV single-shot spin-echo echo planar imaging sequence with outer volume suppression 16 to assess microstructural changes of the whole spinal cord. 
Image processing Lesion segmentation
With the use of the Jim 6.0 software (Xinapse Systems, Aldwincle, UK), the lesion was segmented on the midsagittal T2-weighted images, being visible as a high-signal-intensity area within the spinal cord, as previously described. 7 The following parameters were quantified: midsagittal anteriorposterior lesion width (equal to the maximal anteriorposterior width of the lesion), midsagittal rostrocaudal lesion length (equal to the maximal caudocranial extent of the lesion), total midsagittal lesion area, and midsagittal thickness of midsagittal ventral and dorsal tissue bridges at the widest point of the lesion, which was summed up to the total amount of midsagittal tissue bridges.
Processing of high-resolution macrostructural data above the level of injury
We used serial longitudinal registration 17 embedded within SPM12 to average the five 3-dimensional MEDIC volumes, accounting for intraparticipant motion. To further increase the signal-to-noise ratio, the average volume was resampled at a double slice thickness. We then used the Jim 6.0 software to measure cross-sectional spinal cord area (SCA) of 3 slices. After the midpoint of the spinal cord was marked manually in each slice, the SCA was calculated automatically with the semiautomatic 3-dimensional active-surface model. 18 Gray matter area (GMA), dorsal column area (DCA), VHA (approximately lamina VI-IX), and DHA (approximately lamina I-V) were extracted manually. 6 White matter area (WMA) was calculated by subtracting the GMA from the SCA. The mean interobserver reliability and intraobserver reliability for these measures were previously shown. 8, 16 Preprocessing and estimation of DTI data All processing of the DTI data was carried out with a modified version of the MatLab-based ACID toolbox optimized for the spinal cord. First, we reduced the in-plane FOV to 24 × 24 mm 2 to exclude much of the non-spinal cord tissue in each participant. Then, DTI volumes were slice-wise linearly registered with 3 df (translation in the frequency-and phaseencoding direction, scaling in the phase-encoding direction) to correct for intraparticipant motion and eddy-current artifacts. 19 A diffusion tensor was fitted by use of a robust tensor fitting algorithm that accounts for outlier volumes due to motion and physiologic artifacts. 20 The following DTI index maps were extracted: fractional anisotropy (FA) and mean, axial, and radial diffusivity (MD, AD, and RD). These DTI index maps were then spatially normalized to a self-constructed mean diffusivity template residing in the spinal Montreal Neurological Institute space. 21 To further refine the accuracy of the registration, a manual slice-by-slice registration (in-plane translation and scaling) was performed. Finally, all DTI index maps were smoothed with a full width at half-maximum gaussian kernel with 0.5 × 0.5 × 5 mm 3 .
Statistical analysis
Statistical analysis of all macrostructural MRI, neurophysiologic, and clinical data was performed with Stata13 (StataCorp LP, College Station, TX). The mean age was not statistically different between healthy controls and patients (Mann-Whitney U test: z = −1.61, p = 0.10). All images were visually inspected for artifacts, and the analysis was conducted on 3 slices from each modality at the same level.
First, we assessed the morphometric differences in SCA, GMA, WMA, DCA, VHA, and DHA between patients and healthy controls by means of analysis of covariance, adjusted for age. For microstructural differences between patients and healthy controls, we used SPM12 for voxel-based analysis of the different DTI indexes (FA, MD, AD, RD) by means of analysis of covariance, adjusted for age. All statistical parametric maps were initially thresholded with a clusterdefining threshold of p < 0.01 (uncorrected) and clusters surpassing a cluster threshold of p < 0.05 (family-wise error corrected) are reported. Next, we used linear regression analysis to investigate the relationship between changes at the lesion site (midsagittal lesion area, length and width, and size of midsagittal tissue bridges) and remote cord macrostructural and microstructural changes. We then determined associations between macrostructural (SCA, GMA, WMA, DCA, VHA, and DHA) and microstructural (DTI indexes within lateral corticospinal tract, dorsal column, and spinal lemniscus) parameters and tract-specific clinical measures (motor, pinprick, and light-touch score, GRASSP, SCIM) using linear regression models, adjusted for age and lesion area. Finally, we investigated associations between macrostructural and microstructural MRI indexes and neurophysiologic outcome measures using linear regression models, adjusted for age and lesion area. The level of significance was set to p < 0.05.
Results
Radiologic, clinical, and neurophysiologic characteristics Patients were scanned 6.7 ± 7.8 years after injury. An area of hyperintense signal was visible on the T2-weighted sagittal images in 16 patients (figure 1, A and B); 13 patients showed hyperintensities in their dorsal column, covering on average 41.4 ± 21.0% of the whole dorsal column, and 2 patients showed hyperintensities in the dorsolateral funiculus (e.g., corticospinal tract). The radiologic level of injury (hyperintense T2-weighted signal) covered the vertebral level C3-5 in 1 patient, C3 in 1 patient, C4 in 2 patients, C4-5 in 1 patient, C5 in 2 patients, C6 in 2 patients, C6-7 in 4 patients, and C7 in 2 patients. Two patients showed no signal alteration within the cord. The average lesion area was 45.4 ± 66.6 mm 2 with a lesion length of 11.3 ± 9.4 mm and a lesion width of 4.3 ± 3.5 mm. In 2 patients, the lesion occupied the full cord area, and no midsagittal tissue bridges could be identified. In the remaining 15 patients, the midsagittal tissue bridges had an average width of 2.9 ± 1.9 mm. No magnetic resonance abnormalities were identified in the control group.
Two patients were motor and sensory complete; 2 patients were motor complete and sensory incomplete; and the remaining 13 patients were motor and sensory incomplete. The motor score (maximum 100) was 68.1 ± 30.4; the light-touch score was (mean ± SD) 66.3 ± 32.7 (maximum 112); and the pinprick score (maximum 112) was 52.7 ± 35.0. Manual dexterity was impaired as assessed by the GRASSP score (149.8 ± 66.3 [maximum 232]), and functional independence was impaired as assessed by the SCIM score ([63.1 ± 31.3 [maximum. 100]). Eight patients were able to walk independently (20 of 20 points in the WISCI score); 2 patients were dependent on walking aids (5 of 20 and 9 of 20 points in the WISCI score); and 7 patients were not able to walk (0 of 20 points). All data are summarized in table 1.
All patients had neurophysiologic impairment of the spinothalamic tract, and a majority had impaired function of the dorsal column below the level of lesion as assessed by CHEPs and SSEPs, respectively. The mean ± SD perception/pain thresholds and the amplitudes and latencies of the recorded signals are shown in ). In patients, the DHA was decreased bilaterally by figure 3A) . Greater lesion length and preserved midsagittal tissue bridges were 
Discussion
This study shows the in vivo structure-function relationship between the extent of tissue-specific cord pathology and neurophysiologic and clinical impairment after traumatic SCI. Crucially, we show that the magnitude of tissue damage at the lesion epicenter is associated with the extent of neurodegeneration above the level of lesion, which, in turn, is associated with clinically relevant impairment and neurophysiologic abnormalities. These findings allow us to investigate the extent of tissue-specific neurodegeneration above the level of injury, its relationship to neuronal tissue loss at the site of the lesion, and its effect on neurophysiologic and clinical outcome.
Tissue damage at the epicenter of a traumatic SCI results both from the direct effect of the traumatic insult and from damage to the vascular architecture and the ensuing ischemic effects on the neuronal and glial cell populations within the acute phase of injury. 23 Remote from the epicenter of the lesion, secondary neurodegeneration within white 24, 25 and gray matter 26 follows with a time lag and is driven by a multiphasic response to cellular inflammation. 27 While the extent of secondary remote atrophy has been quantified in vivo after injury, 2,28-30 we provide evidence that changes within both gray and white matter contribute to cord atrophy above the level of injury. This is in agreement with spinal gray matter degeneration distant to the initial site of damage in patients with multiple sclerosis 31 and experimental SCI. 32 Although the relative decrease is larger within ventral and dorsal horns (i.e., gray matter), the absolute magnitude of change is larger within white matter, contributing more to the overall loss of SCA by 20.2%.
We uncovered an in vivo relationship between neuronal tissue loss (i.e., lesion severity) and remote tissue-specific cord pathology above the level of injury. Moreover, we show an interdependence of remote white and gray matter atrophy (i.e., DHA and DCA). Neurodegenerative changes within gray matter above the level of injury are not likely to be specific for any single pathologic process but rather are likely to represent a combination of different pathologic mechanisms taking place after SCI. Possible mechanisms involve transsynaptic/transneuronal degeneration affecting the propriospinal systems 33, 34 and motor neurons located in the proximity of the spinal injury. 35 Next to direct effects of neurodegenerative processes, a reduction in muscle activity of the upper extremity could lead to a reduction of neuronal activity above the level of injury, which may translate into shrinkage of the neuron soma size.
Furthermore, demyelination of corticospinal projections to the dorsal horns, 36 the expression of neurotrophic factors from nonneuronal cells around neighboring degenerating axons, 36 growth factor dysregulation, 37 and vascular remodeling 38 could contribute to gray matter pathology. As white matter damage is known to induce microglial activation altering glutamate signaling, this process is thought to be responsible for the dying back of axons and their parternal neurons, 39 which might be a shared underlying disease mechanism. Thus, next to anterograde and retrograde degeneration of white matter tracts 30, 40, 41 the neuronal circuits within the spinal cord far above the level of injury undergo a temporary structured neurodegeneration. 25 Within the microstructure of the atrophied white matter, we found indications of both axonal degeneration and demyelination, 42 represented by decreased FA and AD and increased RD in the dorsolateral funiculus (e.g., containing the lateral corticospinal and spinothalamic tracts) and posterior funiculus (e.g., containing the dorsal columns). Within the corticospinal tract and the dorsal column, leg function is represented most laterally, whereas arm function is located either medially (i.e., corticospinal tract) or centrally (i.e., dorsal column). Our observed changes cover the entire lateral corticospinal tract and the dorsal columns, indicating neurodegenerative processes affecting axons that convey information relating to leg and arm function. Spatially overlaying the different DTI metrics changes revealed that regions showing decreased AD (e.g., axonal degeneration) but unaltered RD (e.g., no demyelination) lie mostly adjacent to the gray matter border. This region contains the fasciculi proprii and contains mostly short, mainly unmyelinated propriospinal neurons. 43 This underlies our hypothesis that SCI might lead to degeneration affecting interneurons within the spinal cord.
Our findings complement previous studies in patients with SCI 20, [44] [45] [46] in that they now locate these changes to gray and white matter rather than being nonspecific in terms of location and tissue. Thus, our in vivo cord MRI measurements demonstrate a combination of structural and functional processes occurring over several segments above the level of injury affecting both gray and white matter that is driven by lesion severity.
We show that tract-specific microstructural and macrostructural changes are associated with prolonged conduction of appropriate electrophysiologic recordings. This association suggests a structure-function relationship because the amount of neurodegeneration was directly associated with impairment of neurophysiologic information flow. Because the DTI signal is sensitive to altered diffusion properties occurring as a response to CNS damage (i.e., demyelination/degeneration) and because neuronal excitability is affected by morphometry of the axon and its myelin, it seems plausible that neurophysiologic changes might be reflected in remote macrostructural and microstructural changes above the level of injury. Our findings complement previous findings showing that the topography and the excitability of corticomotor projections were associated with cervical cord atrophy. 2, 47 Current assessments in patients with SCI lack sensitivity to minimal changes in motor and sensory function 48 in that they cannot detect subtle changes due to remyelination and axonal regeneration. Neuroimaging biomarkers have the potential to track these subtle abnormalities because they are sensitive to microstructural changes. 1 In this study, the magnitude of both remote macrostructural and microstructural changes within gray and white matter was significantly associated with clinical impairment, independently of lesion extent. In particular, the extent of remote ventral horn atrophy was associated with motor impairment, whereas dorsal horn atrophy was associated with sensory disturbance. Microstructural tract-specific changes above the level of injury were related to measures of functional independence (i.e., SCIM) and strength, sensibility, and prehension of the upper limbs (i.e., GRASSP). This suggests that high-resolution MRI sequences applied above the level of injury provide superior information on the patient's clinical status compared to standard clinical sequences at the lesion site. In addition, the latter findings are striking in that they suggest that remote neurodegeneration within gray matter above the level of injury contributes, in addition to white matter pathology, to motor and sensory impairment. This multilevel interaction supports the view that SCI leads to a cascade of neurodegenerative changes affecting the entire spinal cord and brain. 49 Characterizing these secondary neurodegenerative events has the potential to provide insights into new therapeutic interventions, in addition to providing opportunities for monitoring treatment effects in trials conducted in patients with acute and chronic SCI. This study had several limitations. Although our cohorts did not show a significant age difference, the mean age was on average higher in the patient group, which could potentially affect the analysis. We therefore adjusted for age as a potential confounder of no interest in all analyses. Furthermore, unbiased voxel-based morphometry of DTI indexes in the spinal cord has just started emerging, 3 and the automated postprocessing methods for spatial normalization of the spinal cord into common space are in their infancy. To increase the reliability of our analysis, we therefore manually corrected the spatial normalization to the template.
This study shows that the magnitude of dorsal and ventral horn and white matter structural changes above the level of injury is associated with appropriate clinical and neurophysiologic impairment and is driven by lesion severity. These findings suggest a combination of different pathologic processes affecting both gray and white matter several segments above the level of injury that are clinically eloquent. Therefore, these neuroimaging biomarkers might serve as promising surrogate markers for future clinical trials supplementing (or complementing) clinical outcome measures.
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Summary answer
The magnitude of tissue damage to both grey and white matter at the lesion epicenter is associated with the extent of neurodegeneration above the level of the lesion, which is in turn associated with clinical impairments and neuropsychologic abnormalities, in SCI.
What is known and what this paper adds White matter pathology within the spinal cord contributes to sensorimotor impairments. This study provides evidence that changes within grey matter-driven by the severity of the lesion-also contribute to atrophy above the level of injury and relate to clinical impairment, suggesting that neuroimaging biomarkers can be used to supplement clinical outcome measures in future clinical trials.
Participants and setting
The study included 17 patients with SCI (mean age: 48.7 ± 14.1 years) who had been admitted to University Hospital Balgrist (Zurich, Switzerland) and 21 healthy controls (mean age: 41.7 ± 11.3 years) recruited from among the local population. Inclusion criteria for patients with SCI were as follows: traumatic cervical SCI, absence of other neurologic or psychologic disorders, age 18-70 years, absence of contraindications for MRI, and absence of pregnancy. [SSEPs] ). Contact heatevoked potentials (CHEPs), somatosensory-evoked potentials (SSEPs), and imaging findings were examined an average of 6.7 ± 7.8 years after injury.
Design
Main results and the role of chance Greater lesion area and length were associated with greater decreases in spinal cord area above the level of injury (p = 0.048 and p = 0.006, respectively). Tissue-specific neurodegeneration was associated with electrophysiologic abnormalities. Dorsal and ventral horn atrophy were associated with sensory and motor outcomes, respectively. White matter integrity was associated with functional independence.
Bias, confounding, and other reasons for caution Mean age was higher in the patient group, and manual correction was performed for spatial normalization.
Generalizability to other populations
The results may be generalizable to nontraumatic SCI forms. 
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